Le Lézard
Classified in: Health
Subject: PLW

Hollywog LLC Issued US Patent Covering Mobile Device Control of a TENS Therapy Unit


CHATTANOOGA, Tenn., Sept. 21, 2017 /PRNewswire/ -- Hollywog LLC, a consumer-focused medical device company in Tennessee that creates innovative solutions for a pain-free and healthy life, is pleased to announce the US Patent and Trademark Office has just awarded an important new patent that will advance the field of pain relief entitled "Portable TENS Apparatus and Method of Use Thereof." The patent covers a technological innovation where a portable TENS device can be operated by a wireless remote controller, such as an app on a mobile phone.  This supports a connected health platform for TENS devices, and enables Hollywog and its licensing partners to build digital health solutions.

Hollywog, WiTouch Pro, Wireless Tens Unit, www.hollywog.com

Chuck Thomas, CEO of Hollywog LLC states, "We are pleased to be issued this milestone patent. As the inventors of the first wireless, remote-controlled TENS device, our mission is to keep people moving by bringing state-of-the-art solutions to market.  We continue to be focused on consumer health and recognize the increasing role that connected devices and data analytics can play to help people suffering with chronic pain.  This patent signals an important leap forward where digitally enabled pain management solutions will offer people drug-free alternatives to relieve their pain and keep moving."

Hollywog LLC is the inventor and manufacturer of a portfolio of ergonomic, aesthetically pleasing, and effective pain relief products, including the WiTouch® Wireless TENS Therapy Device and the ModPodtm Cervical Mobilization Device.  Hollywog is a global company, selling pain relief solutions in the US and Europe.  Its products can be found in the US through online distributors and in European retail pharmacies.  They additionally license their IP to third parties, including Bayer Healthcare LLC for the Aleve ® Direct Therapy TENS Device in the USA and Canada.  For more information on their products and where to buy, visit https://www.hollywog.com/

Questions and press inquiries can be directed to Dwayne Hofstatter, Chief Sales and Marketing Officer at [email protected]

Hollywog LLC, Keep Moving
2830 Amnicola Highway, Chattanooga, TN 37406

SOURCE Hollywog LLC


These press releases may also interest you

at 08:40
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that, further...

at 08:33
Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors ? Dr. Luke Solon and Debbie Allman ? to help shape and drive Prescient's global mission....

at 08:31
Snufff, the innovative nasal inhaler, emerges onto the wellness and lifestyle scene, offering a refreshing blend of enjoyment and health benefits. Crafted in the vibrant heart of Singapore, Snufff aims to revolutionize the way we approach personal...

at 08:31
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") , a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the...

at 08:15
MGI Tech, a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a Gold Edison Award in the "Health, Medical & Biotech" category....

at 08:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company sought an extension of its previously announced stay of proceedings ("Stay") under the Companies' Creditors Arrangement Act (the "CCAA") at a hearing before the Ontario...



News published on and distributed by: